Nanoparticle-mediated targeted drug delivery for breast cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoparticle-mediated targeted drug delivery for breast cancer treatment

Published:2019-04 Issue:2 Volume:1871 Page:419-433
ISSN:0304-419X
Container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Author:

Liyanage Piumi Y.,Hettiarachchi Sajini D.,Zhou Yiqun,Ouhtit Allal,Seven Elif S.,Oztan Cagri Y.,Celik Emrah,Leblanc Roger M.

Funder

National Institutes of Health

National Science Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Oncology

Reference172 articles.

1. A Cancer Source Book for Nurses;Varricchio,2004

2. Breast Cancer Facts & Figures 2017–2018;Society,2017

3. Male breast cancer;Fentiman;Lancet,2006

4. A case report of male breast cancer in a very young patient: what is changing?;Madeira;World J. Surg. Oncol.,2011

5. Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells;Mu;Nanoscale,2015

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocellulose derived from agricultural biowaste by-products–Sustainable synthesis, biocompatibility, biomedical applications, and future perspectives: A review;Carbohydrate Polymer Technologies and Applications;2024-12

2. Small molecules targeting mitochondria as an innovative approach to cancer therapy;Cellular Signalling;2024-12

3. Graphene oxide nanoribbons conjugated with 1, 2-distearoyl-sn-glycero-3 phosphoethanolamine-poly (ethylene glycol)-transferrin enhanced targeted delivery and cytotoxicity of raloxifene against breast cancer;International Journal of Biological Macromolecules;2024-10

4. Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review;Journal of Drug Delivery Science and Technology;2024-10

5. In vitro cytotoxic activity of chemically synthesized ZnTe nanoparticles against human lung cancer cell line L-132 with supported molecular docking study;Materials Chemistry and Physics;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3